SEPTEMBER 2015 ARTICLE LIST >>
PharmaTutor (September- 2015)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 9)
Received On: 17/05/2015; Accepted On: 22/05/2015; Published On: 01/09/2015
AUTHORS: *S R Thorat1, S M Meshram2
1Lupin Research Park, Hinjewadi, Pune, Maharashtra
2TATA Consultancy Services, Hinjewadi, Pune, Maharashtra
ABSTRACT: Pressurized metered dose inhalers (MDIs) are widely used dosage form for treatment of respiratory diseases, such as asthma and chronic obstructive pulmonary disease. The metered dose inhaler (MDI) contains the active pharmaceutical ingredient dispersed or solubilised in a high vapour pressure propellant and metered accurately in tens to hundreds of micrograms and administered directly to the lungs. The most dominant characteristics of MDI include their portability, convenience of use and quick effect. MDI comprises of drug formulation, propellant, metering valve, actuator, and container. This review contains overview of excipient selection, primary packaging material, propellant selection and formulation development of pMDI. Two of the most commonly used methods for the manufacturings of MDIs are cold filling method and pressure filling method. This review demonstrates different analytical techniques for characterization of pMDI’s like uniformity of delivered dose, water content, spray pattern and plume geometry were discussed. This review also presents in-vitro characterization, pharmacokinetic and pharamcodynamic study of MDI.
How to cite this article: SR Thorat, SM Meshram; Formulation and product development of pressurised metered dose inhaler: An overview; PharmaTutor; 2015; 3(9); 53-64
[ABSTRACT WITH CITATION] [VIEW AS HTML]
1. Shah N.D., Shah V.V. and Chivate N.D., Pulmonary Drug Delivery: A Promising Approach, J. Appl. Pharma. Sci.; 201202 (06); 33-37
2. Karhale A.A., Chaudhari H.S., Ughade P.L., Baviskar D.T., Jain D.K. Pulmonary Drug Delivery System, Int. J. of Pharm Tech Research; 2012; 4(1); 293- 305
3. Fabio P. and Luiz V.; Advances in inhalation therapy in pediatrics, J. de Pediatria; 2010; 86(5); 367-376
4. Tangri P. and Khurana S., Approaches to pulmonary drug delivery systems; IJPSR 2011; 2(7); 1616-1622
5. Stephen P. N.; Principles of Metered-Dose Inhaler Design; Respiratory care; 2005; 50(9); 1177-1190
6. Dean R. H., Aerosol Delivery Devices in the Treatment of Asthma; Respiratory care; 2008; 53(6); 699-725
7. Patel N.P., Patel A.A. and Modasiya M.K.; Aerosols: Pulmonary drug delivery system; Int. J. of Pharm. and Chem. Sci.; 2012; 1(1); 19-24
8. Ramteke K.H., Gunjal S.S. and Sharma Y.P., Formulation and Quality Control of Metered Dose Inhaler: A Review. J. of Pharma. Innovation ; 2010; 1(2); 44-49
9. Terzano C.; Metered dose inhalers and spacer devices; E. Review Med. and Pharmaco. Sci.; 1999; 3(4); 159-169.
10. Lahkar S.; An overview on : Pharmaceutical Aerosol; Int. Res. J. of Pharm.; 2012, 3(9); 68-75
11. Ibiapina C.C., Cruz A., and Camargos A.; Hydrofluoroalkane as a propellant for pressurized metered-dose inhalers; J. de Pediatria;2004; 80(6); 441-446
12. Ganderton D., Lewis D., Davies R., Meakin B., and Church T.; The formulation and evaluation of CFC free Budesonide pMDI; Respiratory medicine; 2003; Supplement D; S4-S9.
13. Giri M. M., Dr. Ashish Mungantiwar, Bhanu Pratap Sahu, Saha S.; Effect of fine lactose fraction on in vitro deposition of Mometasone furoate dry powder inhaler; Sch. Acad. J. Pharm., 2013; 2(3); 260-267
14. Saleem I.M., Hugh D.C.; Tuning Aerosol Particle Size Distribution of Metered Dose Inhalers Using Cosolvents and Surfactants; BioMed Research Int.; 2013; 1-7
15. British pharmacopoeia. Preparations for inhalations: International edition, 1998, 2; 740-742.
16. Indian Pharmacopoeia Val 2; The Indian Pharmacopoeia Commission, Ministry of Health and Family Walefare, Govt of India, Gaziabad; 2010; 726-740
17. Marple V. A., Bernard Olson, K. santhanakrishnan, Roberts D., Jolyon Mitchell; Next Generation Pharmaceutical Impactor: A New Impactor for Pharmaceutical Inhaler Testing. Part III Extension of Archival Calibration to 15 L/min; J. of aerosol medicine; 2004; 17(4); 335-343
18. Guidelines for Industry; Bioequivalence requirement of Albuterol Sulfate Metered Dose Inhaler (MDI); Center for Drug Evaluation and Research (CDER); 2013